Literature DB >> 7237964

Toxicity with intravenous injection of crude marijuana extract.

N D Vaziri, R Thomas, M Sterling, K Seiff, M V Pahl, J Davila, A Wilson.   

Abstract

Intravenous injection of crude marijuana extract led to development of an acute illness with multisystem involvement. Gastrointestinal manifestations consisted of severe vomiting, diarrhea, and crampy abdominal pain. Hypotension, tachycardia, and peripheral vasodilation constituted the main cardiovascular manifestations of the disease. Moderate azotemia and oliguria, presumed to be of prerenal origin, were present and rapidly resolved with administration of intravenous fluids. Hematologic manifestations consisted of leukocytosis with a left shift, thrombocytopenia, prolonged partial thromboplastin time, increased fibrin degradation products, and positive protamine sulfate test. The observed coagulation abnormalities may suggest intravascular coagulation. C3, C4, and total hemolytic complement were reduced, suggesting possible activation of the complement system. Hyperventilation, hypoxemia, pulmonary edema, obstructive, and restrictive pulmonary function abnormalities and bilateral pleural effusions highlighted the pulmonary manifestations of the disease. Rhadbomyolysis and mild hepatic function abnormalities were also present. All observed abnormalities reversed in a few days with no significant sequelae.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7237964     DOI: 10.3109/15563658108990042

Source DB:  PubMed          Journal:  Clin Toxicol        ISSN: 0009-9309            Impact factor:   4.467


  13 in total

1.  Cannabinoid hyperemesis.

Authors:  Kim Wild; Hugh Wilson
Journal:  BMJ Case Rep       Date:  2010-09-07

2.  Intravenous marijuana syndrome.

Authors:  D Brandenburg; R Wernick
Journal:  West J Med       Date:  1986-07

3.  The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States.

Authors:  Maria Soriano-Co; Mihaela Batke; Mitchell S Cappell
Journal:  Dig Dis Sci       Date:  2010-02-04       Impact factor: 3.199

4.  Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse.

Authors:  Siva P Sontineni; Sanjay Chaudhary; Vijaya Sontineni; Stephen J Lanspa
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

5.  Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse.

Authors:  J H Allen; G M de Moore; R Heddle; J C Twartz
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

6.  Cannabinoid hyperemesis relieved by compulsive bathing.

Authors:  Yoon Hee Chang; Donna M Windish
Journal:  Mayo Clin Proc       Date:  2009       Impact factor: 7.616

Review 7.  Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms.

Authors:  Marieka V DeVuono; Linda A Parker
Journal:  Cannabis Cannabinoid Res       Date:  2020-06-05

8.  Cannabidiol Interferes with Establishment of Δ9-Tetrahydrocannabinol-Induced Nausea Through a 5-HT1A Mechanism.

Authors:  Marieka V DeVuono; Olivia La Caprara; Gavin N Petrie; Cheryl L Limebeer; Erin M Rock; Matthew N Hill; Linda A Parker
Journal:  Cannabis Cannabinoid Res       Date:  2020-12-21

9.  Compulsive showering and marijuana use - the cannabis hyperemisis syndrome.

Authors:  Fawwaz Mohammed; Kirby Panchoo; Maria Bartholemew; Dale Maharaj
Journal:  Am J Case Rep       Date:  2013-08-23

10.  Association of marijuana use and cyclic vomiting syndrome.

Authors:  Mithun B Pattathan; Reza A Hejazi; Richard W McCallum
Journal:  Pharmaceuticals (Basel)       Date:  2012-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.